How to Hire Life Sciences Talent Strategically During Market Uncertainty
May 20268 min read
How to Hire Life Sciences Talent Strategically During Market Uncertainty
Throughout 2026, hiring sentiment across the life sciences sector has remained cautiously optimistic. While investment activity has stabilised across many areas of pharmaceuticals, biotechnology, medical devices, and life sciences services, organisations continue to navigate economic pressure, geopolitical uncertainty, regulatory complexity, and rising operational costs.
At the same time, demand for specialist talent has not disappeared. Companies are still competing for experienced professionals across commercial, technical, regulatory, manufacturing, and R&D functions, particularly those capable of supporting growth, innovation, and operational resilience in uncertain conditions.
There is certainly upward momentum in the life sciences talent market at the moment, with a number of businesses returning to consistent levels of growth. However, there is increasing uncertainty within the market linked to geopolitical and economic factors including the energy cost crisis currently unfolding. We still observe large gaps in talent demand versus talent availability, especially at mid-senior levels where candidates with strong technical and end-market commercial experience are highly sought after.
For employers, this does not mean pausing hiring altogether. Instead, it means becoming more strategic about where hiring investment delivers the greatest long-term impact.
Why leading life sciences employers are still hiring in cautious markets
Despite broader market uncertainty, many life sciences Organisations continue hiring selectively across core business-critical functions. The reality is that innovation pipelines, regulatory obligations, manufacturing timelines, and commercialisation goals do not stop during slower economic cycles.
Organisations developing advanced therapies, scaling manufacturing capacity, navigating evolving regulatory frameworks, or launching new products still require specialist talent to maintain momentum. Delaying hiring in these areas can quickly create operational bottlenecks, compliance risks, delayed commercialisation, or lost market share.
At the same time, companies are balancing growth ambitions with tighter budget scrutiny.
Zach comments:
Companies are once again balancing the need for talent with being acutely cost-conscious and are scrutinizing who to hire, and how to hire. As with most times of uncertainty, the contract market continues to be resilient as organisations engage contractors directly while permanent hiring is being assessed.
This is particularly visible across:
- Regulatory affairs and quality assurance
- Manufacturing science and technology (MSAT)
- Automation and engineering
- Clinical development and pharmacovigilance
- Commercial leadership and market access
- AI-enabled diagnostics and digital health
- Cell and gene therapy operations
- Specialist sales and applications support
Across these functions, businesses are prioritising hires that directly support revenue generation, operational continuity, regulatory readiness, and long-term capability building.
Where competitors are investing in life sciences talent
While some organisations remain cautious, others are using the current market to secure specialist talent before hiring activity accelerates again.
Commercial and go-to-market talent
Commercial hiring remains highly competitive, particularly for professionals who combine technical expertise with modern consultative sales capability. Organisations increasingly want commercially minded talent that can navigate complex customer environments, leverage digital engagement strategies, and drive growth beyond established networks.
Zach explains:
For permanent hiring there is robust demand for strong, digitally savvy commercial talent who combine deep technical knowledge with consultative, solution-based sales techniques. End-customer networks are still king, but companies are increasingly looking for creativity and digitally minded commercial talent who can penetrate customers and markets beyond their existing book of business.
This is particularly relevant across:
- Medical devices and diagnostics
- Analytical instrumentation
- Biopharmaceutical services
- CDMOs and CROs
- Digital health and AI-driven platforms
- Specialty therapeutics and rare disease markets
- Technical and manufacturing expertise
Demand for experienced technical professionals continues to outpace supply across manufacturing, engineering, validation, automation, quality, and process development functions. Aging workforce demographics and increasing technical complexity are intensifying long-standing talent shortages.
Businesses scaling production capacity or modernising manufacturing infrastructure are particularly focused on securing professionals with highly specialised industry experience.
Contract and interim talent
Contract hiring remains one of the most resilient areas of the life sciences talent market. Many organisations are leveraging interim expertise to maintain flexibility while continuing to progress key projects and regulatory milestones.
This is especially prevalent across:
- Validation and remediation projects
- Regulatory transitions
- Site expansions and technology transfers
- Clinical operations support
- Quality and compliance projects
- Manufacturing scale-ups
According to Zach:
Against this backdrop we see strong and consistent demand for freelance talent in technical end markets as companies look to borrow talent to bridge gaps in their own talent pipeline.
Why top life sciences talent is more accessible during uncertain periods
Periods of market uncertainty often create a unique hiring opportunity. Highly skilled professionals who may not actively seek new roles during high-growth markets become more open to exploring opportunities that offer stronger long-term stability, progression, purpose, and development.
However, candidate priorities have evolved significantly compared to previous years. Compensation remains important, but professionals are increasingly evaluating the full employee value proposition.
Zach explains:
Candidates are assessing all-around factors and compensation packages more than ever before. We no longer have the post-COVID flexibility differentials that we did around 2022, as most organisations have converged around established hybrid working patterns. While flexibility remains highly important, fully remote working is significantly less common than it once was, and office presence is expected in most roles.
Today’s candidates are carefully considering:
- Career progression and long-term growth
- Company stability and market positioning
- Leadership quality and business vision
- Technical innovation and project exposure
- Flexibility and hybrid working structures
- Compensation and broader benefits
- Organisational culture and retention outlook
For employers, this means hiring strategies must become more transparent, structured, and candidate-centric.
The cost of moving too slowly
One of the biggest risks in the current market is assuming that talent availability automatically means easier hiring. The strongest candidates, however, remain highly competitive and often manage multiple interview processes simultaneously.
Zach advises:
Move quickly. We have seen several examples recently where strong talent had multiple advanced-stage interviews and needed to decide between competing offers. We advise our clients to maintain hiring process momentum, as delays during interview processes can often result in preferred candidates being snapped up by competitor organisations that are able to move more quickly.
Slow hiring processes can create several challenges:
- Losing high-performing candidates to faster competitors
- Increased vacancy costs and project delays
- Additional pressure on existing teams
- Reduced employer brand perception
- Higher counteroffer risk
This is especially critical in specialist life sciences markets where talent pools are already limited.
Retention is becoming just as important as hiring
As organisations continue competing for specialist talent, retention has become equally important to attraction strategies. Businesses are increasingly recognising the operational and financial impact of losing highly experienced professionals in niche functions.
Zach comments:
Companies are increasingly realising that losing a highly experienced life sciences professional is problematic and costly, and we are seeing increased levels of counteroffers.
However, counteroffers alone rarely solve underlying retention challenges. Many professionals ultimately decline them due to concerns around trust, long-term progression, or organisational stability.
Instead, companies are focusing more heavily on:
- Clear career development pathways
- Transparent leadership communication
- Skills development and technical training
- Fair and competitive compensation structures
- Sustainable workloads and team support
- Realistic flexibility policies
How to improve your life sciences hiring strategy in 2026
In uncertain markets, hiring success often comes down to precision rather than volume. The organisations performing best are those aligning hiring decisions directly to business-critical priorities.
Key focus areas include:
Prioritize business-critical functions
Focus hiring investment on roles that directly support:
- Revenue growth and commercialisation
- Regulatory compliance and audit readiness
- Manufacturing continuity and scalability
- Innovation and product development
- Digital transformation and automation
- Succession planning and leadership continuity
Strengthen hiring agility
Review interview processes to ensure decision-making is fast, aligned, and candidate-focused. Top candidates will not remain available indefinitely.
Utilize flexible workforce strategies
Interim and contract professionals can provide critical expertise while allowing organisations to remain adaptable during uncertain market conditions.
Improve retention planning
Regularly benchmark compensation, progression opportunities, and workforce engagement against market expectations to reduce preventable attrition.
Build future talent pipelines early
Organisations that proactively engage specialist talent before hiring becomes urgent are often best positioned when market activity accelerates.
Checklist: key life sciences hiring priorities for 2026
Practical steps employers can take now include:
- Map hiring priorities against business-critical objectives
- Benchmark compensation and retention competitiveness
- Identify areas where talent shortages create operational risk
- Build pipelines for specialist and leadership talent early
- Keep interview processes efficient and aligned
- Strengthen contractor and interim talent strategies
- Review progression and development plans for mid-senior employees
- Improve employer branding and candidate communication
- Prepare for increased counteroffer activity
- Ensure hiring managers can clearly articulate long-term business vision
Build the life sciences teams your competitors will wish they secured earlier
Market uncertainty is creating a rare strategic hiring window across life sciences. While some organisations hesitate, others are securing the specialist and senior talent needed to strengthen operations, accelerate growth, and prepare for future market demand.
EPM Scientific partners with life sciences organisations across pharmaceuticals, biotechnology, medical devices, chemical technology, and life sciences services to solve complex hiring challenges through specialist market expertise, global talent networks, and deep insight into compensation, hiring trends, and candidate expectations.
Request a call back today to discuss how your organisation can hire the specialist life sciences talent needed to navigate uncertainty and emerge stronger.